A Study of Penpulimab and Anlotinib Plus Nab-paclitaxel and Gemcitabine for Metastatic Pancreatic Cancer.
Conditions
Interventions
- DRUG: Penpulimab
- DRUG: Anlotinib
- DRUG: Nab paclitaxel
- DRUG: Gemcitabine
Sponsor
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Collaborators